These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 29016715)

  • 1. Matrix metalloproteinase-2 knockout prevents angiotensin II-induced vascular injury.
    Barhoumi T; Fraulob-Aquino JC; Mian MOR; Ouerd S; Idris-Khodja N; Huo KG; Rehman A; Caillon A; Dancose-Giambattisto B; Ebrahimian T; Lehoux S; Paradis P; Schiffrin EL
    Cardiovasc Res; 2017 Dec; 113(14):1753-1762. PubMed ID: 29016715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. γδ T Cells Mediate Angiotensin II-Induced Hypertension and Vascular Injury.
    Caillon A; Mian MOR; Fraulob-Aquino JC; Huo KG; Barhoumi T; Ouerd S; Sinnaeve PR; Paradis P; Schiffrin EL
    Circulation; 2017 May; 135(22):2155-2162. PubMed ID: 28330983
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deficiency of T-regulatory cells exaggerates angiotensin II-induced microvascular injury by enhancing immune responses.
    Mian MO; Barhoumi T; Briet M; Paradis P; Schiffrin EL
    J Hypertens; 2016 Jan; 34(1):97-108. PubMed ID: 26630215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T regulatory lymphocytes prevent angiotensin II-induced hypertension and vascular injury.
    Barhoumi T; Kasal DA; Li MW; Shbat L; Laurant P; Neves MF; Paradis P; Schiffrin EL
    Hypertension; 2011 Mar; 57(3):469-76. PubMed ID: 21263125
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin II induces vascular dysfunction without exacerbating blood pressure elevation in a mouse model of menopause-associated hypertension.
    Javeshghani D; Sairam MR; Neves MF; Schiffrin EL; Touyz RM
    J Hypertens; 2006 Jul; 24(7):1365-73. PubMed ID: 16794486
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TIMP3 is the primary TIMP to regulate agonist-induced vascular remodelling and hypertension.
    Basu R; Lee J; Morton JS; Takawale A; Fan D; Kandalam V; Wang X; Davidge ST; Kassiri Z
    Cardiovasc Res; 2013 Jun; 98(3):360-71. PubMed ID: 23524300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective role of vascular smooth muscle cell PPARγ in angiotensin II-induced vascular disease.
    Marchesi C; Rehman A; Rautureau Y; Kasal DA; Briet M; Leibowitz A; Simeone SM; Ebrahimian T; Neves MF; Offermanns S; Gonzalez FJ; Paradis P; Schiffrin EL
    Cardiovasc Res; 2013 Mar; 97(3):562-70. PubMed ID: 23250918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Divergent roles of matrix metalloproteinase 2 in pathogenesis of thoracic aortic aneurysm.
    Shen M; Lee J; Basu R; Sakamuri SS; Wang X; Fan D; Kassiri Z
    Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):888-98. PubMed ID: 25657308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angiotensin-converting enzyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling.
    Patel VB; Zhong JC; Fan D; Basu R; Morton JS; Parajuli N; McMurtry MS; Davidge ST; Kassiri Z; Oudit GY
    Hypertension; 2014 Jul; 64(1):157-64. PubMed ID: 24799609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced vascular remodeling, endothelial dysfunction, and oxidative stress in resistance arteries of angiotensin II-infused macrophage colony-stimulating factor-deficient mice: evidence for a role in inflammation in angiotensin-induced vascular injury.
    De Ciuceis C; Amiri F; Brassard P; Endemann DH; Touyz RM; Schiffrin EL
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2106-13. PubMed ID: 16100037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Consequences of postnatal vascular smooth muscle EGFR deletion on acute angiotensin II action.
    Schreier B; Hünerberg M; Rabe S; Mildenberger S; Bethmann D; Heise C; Sibilia M; Offermanns S; Gekle M
    Clin Sci (Lond); 2016 Jan; 130(1):19-33. PubMed ID: 26438881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atorvastatin prevents angiotensin II-induced vascular remodeling and oxidative stress.
    Briones AM; Rodríguez-Criado N; Hernanz R; García-Redondo AB; Rodrigues-Díez RR; Alonso MJ; Egido J; Ruiz-Ortega M; Salaices M
    Hypertension; 2009 Jul; 54(1):142-9. PubMed ID: 19451411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AVE0991, a nonpeptide angiotensin-(1-7) mimic, inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E knockout mice.
    Ma H; Wang YL; Hei NH; Li JL; Cao XR; Dong B; Yan WJ
    J Mol Med (Berl); 2020 Apr; 98(4):541-551. PubMed ID: 32060588
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of endothelial NF-κB signalling in vascular remodelling and aortic aneurysm formation.
    Saito T; Hasegawa Y; Ishigaki Y; Yamada T; Gao J; Imai J; Uno K; Kaneko K; Ogihara T; Shimosawa T; Asano T; Fujita T; Oka Y; Katagiri H
    Cardiovasc Res; 2013 Jan; 97(1):106-14. PubMed ID: 23015640
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiotensin-II induced hypertension and renovascular remodelling in tissue inhibitor of metalloproteinase 2 knockout mice.
    Pushpakumar S; Kundu S; Pryor T; Givvimani S; Lederer E; Tyagi SC; Sen U
    J Hypertens; 2013 Nov; 31(11):2270-81; discussion 2281. PubMed ID: 24077247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PARP-1 (Poly[ADP-Ribose] Polymerase 1) Inhibition Protects From Ang II (Angiotensin II)-Induced Abdominal Aortic Aneurysm in Mice.
    Liang ES; Bai WW; Wang H; Zhang JN; Zhang F; Ma Y; Jiang F; Yin M; Zhang MX; Chen XM; Qin WD
    Hypertension; 2018 Nov; 72(5):1189-1199. PubMed ID: 30354818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Attenuated responses to angiotensin II in follitropin receptor knockout mice, a model of menopause-associated hypertension.
    Javeshghani D; Touyz RM; Sairam MR; Virdis A; Neves MF; Schiffrin EL
    Hypertension; 2003 Oct; 42(4):761-7. PubMed ID: 12885794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletion of angiotensin-converting enzyme 2 promotes the development of atherosclerosis and arterial neointima formation.
    Sahara M; Ikutomi M; Morita T; Minami Y; Nakajima T; Hirata Y; Nagai R; Sata M
    Cardiovasc Res; 2014 Feb; 101(2):236-46. PubMed ID: 24193738
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation.
    Diep QN; Amiri F; Touyz RM; Cohn JS; Endemann D; Neves MF; Schiffrin EL
    Hypertension; 2002 Dec; 40(6):866-71. PubMed ID: 12468571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibroblast Nox2 (NADPH Oxidase-2) Regulates ANG II (Angiotensin II)-Induced Vascular Remodeling and Hypertension via Paracrine Signaling to Vascular Smooth Muscle Cells.
    Harrison CB; Trevelin SC; Richards DA; Santos CXC; Sawyer G; Markovinovic A; Zhang X; Zhang M; Brewer AC; Yin X; Mayr M; Shah AM
    Arterioscler Thromb Vasc Biol; 2021 Feb; 41(2):698-710. PubMed ID: 33054395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.